The biomarkers market is estimated to be valued at US$ 55.59 Bn in 2024 and is expected to exhibit a CAGR of 13.6% over the forecast period 2022- 2030, as highlighted in a new report published by Coherent Market Insights. The biomarkers market is primarily driven by the rising prevalence of chronic and lifestyle diseases globally. Biomarkers Read More…
